A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

Study Identifier
M16-119
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Dermatology - Other
  • Study Drug
  • adalimumab
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study is designed to investigate the efficacy, safety and pharmacokinetics of adalimumab in subjects in Japan with active ulcer(s) due to Pyoderma Gangrenosum (PG).

    Study Locations

    Location
    Status
    Location
    Nagoya City University Hospital /ID# 164510
    Nagoya, Aichi-ken, Japan, 467-8602
    Status
    Not applicable
    Location
    Juntendo University Urayasu Hospital /ID# 164422
    Urayasu Shi, Chiba, Japan, 279-0021
    Status
    Not applicable
    Location
    Fukuoka University Hospital /ID# 164416
    Fukuoka, Fukuoka, Japan, 814-0180
    Status
    Not applicable
    Location
    Fukushima Medical University Hospital /ID# 164358
    Fukushima, Fukushima, Japan, 960-1295
    Status
    Not applicable
    Location
    Gunma University Hospital /ID# 164464
    Maebashi, Gunma, Japan, 371-8511
    Status
    Not applicable
    Location
    Asahikawa Medical University Hospital /ID# 164589
    Asahikawa-shi, Hokkaido, Japan, 078-8510
    Status
    Not applicable
    Showing {first} - {last} of {total} Results